MajorClass III antiarrhythmic×SNRI (serotonin-norepinephrine reuptake inhibitor)
Updated · Methodology
Mechanism
Additive QT prolongation. Venlafaxine prolongs QT at high doses; dronedarone carries an FDA boxed warning for this effect.
Symptoms
QT prolongation on ECG. Dizziness, syncope, palpitations. Severe cases progress to polymorphic ventricular tachycardia (torsades de pointes). Risk is higher with hypokalaemia and hypomagnesaemia.
Management
Avoid the combination. Alternative antidepressants with minimal QT effect: mirtazapine or agomelatine. Alternative antiarrhythmic: a beta-blocker for rate control.
Check the full regimen, not just this pair
Opens the checker with these two drugs prefilled. Add the rest of the regimen and recompute additive risks.
Summary of a multi-drug list →
Medicine list: everything you take in one place →
Sources
- FDA: Multaq (dronedarone) prescribing information (2017)– ; DailyMed setid 7fa41601-7fb5-4155-8e50-2ae903f0d2d6
- AEMPS: Ficha técnica: Venlafaxina (nº registro 67542), sección 4.5 (2024)– AEMPS, CIMA, nº registro 67542, revisión 03/2024, sección 4.5